Unjha Formulations P/E Ratio
Current P/E Ratio
8.58
Low Valuation
Very Low - Potentially undervalued or facing challenges
Unjha Formulations (UNJHAFOR) P/E ratio is 8.58 (Low), EPS (TTM) ₹0.91, current price ₹19.30 on BSE — Very Low - Potentially undervalued or facing challenges. Analyse Unjha Formulations ownership pattern to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/E Ratio
8.58
Current Price
₹19.30
EPS (TTM)
₹0.91
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
50.1
Sector Median
29.4
Sector Rank
#11 of 190
Sector Percentile
5.8%
UNJHAFOR P/E Ratio — Valuation Signal & Historical Context
Unjha Formulations P/E 8.58 — signal: Undervalued. Browse UNJHAFOR complete financial statements for revenue, profit, balance sheet and cash flow data.
- Stock appears undervalued with PE of 8.58, suggesting potential buying opportunity
- Trading at discount to sector average PE of 50.1
UNJHAFOR vs Healthcare Peers — P/E Ratio Comparison
Unjha Formulations P/E 8.58 vs Healthcare average 50.1, median 29.4 — range 1.0–869.57.
Sector Average
50.1
Sector Median
29.4
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |